- Home
- Versavo+ 400 mg Infusion 16 ml
Versavo+ 400 mg Infusion 16 ml Substitute
Versavo+ 400 mg Infusion 16 ml Substitute
Avastimab 400mg Injection
by Others
₹2690.63per tabletAdvamab 400 Injection 16 ml
by Others
₹2350.84per tabletAdcimab 400 mg Injection 16 ml
by Others
₹2665.00per tabletHalsbev 400 Injection 16 ml
by Others
₹2818.75per tabletKrabeva 400 mg Injection 16 ml
by Others
₹2214.61per tabletIvzumab 400 mg Injection 16 ml
by Others
₹3254.76per tabletCrognoc 400 Injection 16 ml
by Others
₹1012.50per tabletBryxta 400 Injection 16 ml
by AYUR
₹3279.74per tabletBevarest-400 Injection 16 ml
by Others
₹2720.40per tabletBevazza 400 mg/16 ml Injection 16 ml
by AYUR
₹2346.32per tabletBevicra 400 mg Injection 16 ml
by Others
₹1537.50per tabletBevakalp 400 mg Injection 16 ml
by Others
₹2439.50per tabletBevaro 400 Injection 16 ml
by Others
₹2744.23per tabletBevnexxa 400mg Injection
by Others
₹1998.75per tablet
Verified Ingredients and Effects
Composition:
BEVACIZUMAB-400MG
Uses:
Versavo+ 400 mg Infusion 16 ml is used in the treatment of Metastatic breast cancer, non-small cell lung cancer, kidney cancer, cervical cancer, epithelial ovarian, fallopian tube, or primary peritoneal cancer, cancer of colon and rectum. The detailed uses of Versavo+ 400 mg Infusion 16 ml are as follows:<br/>• Colorectal Cancer: Versavo+ 400 mg Infusion 16 ml is used in combination with chemotherapy for metastatic cases.<br/>• Non-Small Cell Lung Cancer (NSCLC): Versavo+ 400 mg Infusion 16 ml helps slow tumor growth and spread when combined with carboplatin and paclitaxel.<br/>• Ovarian, Cervical, and Peritoneal Cancer: Versavo+ 400 mg Infusion 16 ml is often used post-surgery or with chemotherapy to improve outcomes.<br/>• Renal Cell Carcinoma (Kidney Cancer): Versavo+ 400 mg Infusion 16 ml enhances treatment efficacy when paired with other agents.<br/>• Glioblastoma (Brain Tumor): Versavo+ 400 mg Infusion 16 ml is approved for recurrent cases to reduce tumor vascularization.<br/>• Hepatocellular Carcinoma (Liver Cancer): Versavo+ 400 mg Infusion 16 ml is used in combination with other drugs for advanced stages.<br/>
Medicinal Benefits:
Versavo+ 400 mg Infusion 16 ml contains Bevacizumab, a monoclonal antibody used to treat metastatic breast cancer, non-small cell lung cancer, kidney cancer, cervical cancer, epithelial ovarian, fallopian tube, or primary peritoneal cancer, cancer of colon and rectum. Versavo+ 400 mg Infusion 16 ml works against a protein called vascular endothelial growth factor (VEGF). Vascular endothelial growth factor (VEGF) inhibition limits the flow of oxygen and nutrients to the tumour cells, causing them to shrink or cease developing. Thus, it helps treat cancer.
FAQs
Versavo+ 400 mg Infusion 16 ml is a monoclonal antibody used to treat metastatic breast cancer, non-small cell lung cancer, kidney cancer, cervical cancer, epithelial ovarian, fallopian tube, or primary peritoneal cancer, cancer of colon and rectum.
Versavo+ 400 mg Infusion 16 ml works against a protein called vascular endothelial growth factor (VEGF). Inhibition of vascular endothelial growth factor (VEGF) limits the flow of oxygen and nutrients to the tumour cells, causing them to shrink or cease developing. Thereby, Versavo+ 400 mg Infusion 16 ml helps treat cancer.
Versavo+ 400 mg Infusion 16 ml may reduce the number of red blood cells leading to anaemia. Its symptoms include pale skin, lack of energy, feeling breathless, feeling dizzy and lightheadedness.
Chemotherapy remains necessary. Versavo+ 400 mg Infusion 16 ml is given along with chemotherapy for treating cancer.
Versavo+ 400 mg Infusion 16 ml may increase the risk of bleeding and problems with wound healing. If you have had major surgery in the past 28days or if the wound hasn't healed, you should not take Versavo+ 400 mg Infusion 16 ml. Talk to your doctor for more information.
Cancer can affect anyone, though the risk increases with age. Individual risk is determined by factors such as smoking and drinking habits, lifestyle choices such as what you eat and exercise; a family history of cancer, and factors in your workplace and environment.
Versavo+ 400 mg Infusion 16 ml may increase the incidence of hypertension. Therefore, consult your doctor before taking Versavo+ 400 mg Infusion 16 ml if you have high blood pressure.
Versavo+ 400 mg Infusion 16 ml is given intravenously (into a vein) infusion by a healthcare professional. Versavo+ 400 mg Infusion 16 ml should never be given as an intravenous push or bolus. Do not self-administer.
The duration of treatment with Versavo+ 400 mg Infusion 16 ml depends on your condition and response to the treatment. Your doctor will decide the length of time, based on its effectiveness and your tolerance. Regular monitoring will guide ongoing treatment.
Chemotherapy targets and destroys rapidly dividing cells, including cancer cells, to stop their growth and spread. While, Versavo+ 400 mg Infusion 16 ml works by inhibiting the formation of new blood vessels that supply oxygen and nutrients to tumors. Cutting off this blood supply helps shrink the tumor or prevent it from growing further.
A person taking Versavo+ 400 mg Infusion 16 ml may still require chemotherapy. Versavo+ 400 mg Infusion 16 ml is often used in combination with chemotherapy to treat certain cancers, as it helps prevent tumor growth by blocking blood vessel formation and improves the effectiveness of chemotherapy.
Versavo+ 400 mg Infusion 16 ml causes side effects such as constipation, loss of appetite, fever, nose bleeds, change in speech, voice changes/hoarseness, and loss of body weight. Most of these side effects do not require any medical requirements as they will gradually reduce over time. Contact a doctor if these side effects persist for longer durations.